By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Complete Genomics has filed for the registration of up to $7 million in additional shares in connection to a stock option being offered to employees.

In a document filed with the US Securities and Exchange Commission on Monday, the Mountain View, Calif.-based sequencing services firm registered about 1.6 million shares of its common stock at a proposed maximum offering price of $4.53 per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Sponsored by

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.